AmeriCann Completes Successful 3-Year Partnership with Licensed Colorado Cannabis Producer

DENVER, CO / ACCESSWIRE / June 5, 2017 / AmeriCann, Inc. (OTCQX: ACAN), an Agricultural-Technology company that is developing the next generation of sustainable, state-of-the-art medical cannabis cultivation properties...

Posted by: marijuanaindex.com

DENVER, CO / ACCESSWIRE / June 5, 2017 / AmeriCann, Inc. (OTCQX: ACAN), an Agricultural-Technology company that is developing the next generation of sustainable, state-of-the-art medical cannabis cultivation properties, announced today it has completed a very successful three-year partnership with a licensed Colorado cannabis producer that has resulted in exceptional returns to the company.

In 2014, AmeriCann contributed $1,000,000 in secured funding for the final design and construction of a 15,000 square foot state-of-art cultivation and processing facility in Denver, CO. AmeriCann’s Preferred Partner, 4900 Jackson, LLC, has been a licensed medical cannabis producer in Colorado since 2010.

With the final payment made in May of 2017, AmeriCann received total distributions over the term of the agreement of $1,457,000 from consulting fees, interest and principal repayment. The average annual returns exceeded 15% over the 3 years.

“Our partnership with AmeriCann has been excellent,” stated John Ray, managing partner of 4900 Jackson, LLC. “I learned first-hand of AmeriCann’s commitment to developing the most efficient, technologically advanced cannabis cultivation facilities possible. The innovations in cultivation technology that AmeriCann has developed for its development in Massachusetts are the future of the industry.”

“We are extremely pleased with our partnership with 4900 Jackson, LLC. The financial returns were excellent for our shareholders. As an early-mover in the Colorado market our team gained invaluable first-hand knowledge with innovative cultivation systems and the market dynamics from the most mature regulated market in the nation,” commented Tim Keogh, President and CEO of AmeriCann. “In 2016, Colorado was a $1.2 billion market, which continues to grow, and to participate in such a dynamic market was an excellent experience that we will continue to leverage in new markets throughout the country.”

AmeriCann’s flagship project, the Massachusetts Medical Cannabis Center (“MMCC”), is 47 miles from Boston in the midst of the rapidly growing Massachusetts medical cannabis market. The MMCC project is approved for 1 million square feet, which will be developed in phases and is expected to be one of the most technologically advanced cultivation facilities in the nation. The company is planning to replicate the Cannopy platform in additional states.

Continue reading at MarijuanaIndex.com

Cannabis Stocks AmeriCann